PatientsVille.com Logo

Bevacizumab) Side Effects

PatientsVille

Common Bevacizumab) Side Effects


The most commonly reported Bevacizumab) side effects (click to view or check a box to report):

Back Pain (1)
Blood Albumin Decreased (1)
Asthenia (1)
Aspartate Aminotransferase Increased (1)
Sinus Arrhythmia (1)
Alanine Aminotransferase Increased (1)
Blood Alkaline Phosphatase Increased (1)
Blood Bilirubin Increased (1)
Pulmonary Embolism (1)
Pulmonary Hypertension (1)
Prothrombin Time Prolonged (1)
Decreased Appetite (1)
Blood Sodium Decreased (1)
Activated Partial Thromboplastin Time Prolonged (1)


If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Bevacizumab) Side Effects Reported to FDA


Bevacizumab) Side Effect Report#4969174-8
Activated Partial Thromboplastin Time Prolonged, Prothrombin Time Prolonged, Pulmonary Embolism, Pulmonary Hypertension, Sinus Arrhythmia
This is a report of a 63-year-old female patient (weight: NA) from United States, suffering from the following health symptoms/conditions: ovarian cancer, who was treated with Bevacizumab) Pwdr + Solvent, Infusion Soln, 100mg (dosage: 1118 Mg, Q3w, Intravenous, start time:
May 11, 2005), combined with:
  • Colace (docusate Sodium)
  • Ativan
  • Effexor
  • Multi-vitamins
  • Compazine
  • Revatio (sildenafil Citrate)
and developed a serious reaction and side effect(s): Activated Partial Thromboplastin Time Prolonged, Prothrombin Time Prolonged, Pulmonary Embolism, Pulmonary Hypertension, Sinus Arrhythmia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bevacizumab) Pwdr + Solvent, Infusion Soln, 100mg treatment in female patients, resulting in Activated Partial Thromboplastin Time Prolonged side effect. The patient was hospitalized.
Bevacizumab) Side Effect Report#4735331-9
Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Back Pain, Blood Albumin Decreased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Sodium Decreased, Decreased Appetite
This report suggests a potential Bevacizumab) Pwdr + Solvent, Infusion Soln, 100mg Alanine Aminotransferase Increased side effect(s) that can have serious consequences. A 76-year-old male patient (weight: NA) from United States was diagnosed with the following symptoms/conditions: non-small cell lung cancer and used Bevacizumab) Pwdr + Solvent, Infusion Soln, 100mg (dosage: 1238 Mg) starting
Jul 08, 2005. After starting Bevacizumab) Pwdr + Solvent, Infusion Soln, 100mg the patient began experiencing various side effects, including: Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Back Pain, Blood Albumin Decreased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Sodium Decreased, Decreased AppetiteAdditional drugs used concurrently:
  • Gemzar (2500 Mg)
  • Carboplatin (368 Mg)
The patient was hospitalized. Although Bevacizumab) Pwdr + Solvent, Infusion Soln, 100mg demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Alanine Aminotransferase Increased, may still occur.



The appearance of Bevacizumab) on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Bevacizumab) reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Bevacizumab) Side Effects

    Did You Have a Bevacizumab) Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Bevacizumab) for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Bevacizumab) Safety Alerts, Active Ingredients, Usage Information

    More About Bevacizumab)

    Side Effects reported to FDA: 2

    Bevacizumab) safety alerts: 2012 2010 2008 2007 2006 2005 2004

    Reported hospitalizations: 2

    Altuzan (bevacizumab): Counterfeit Product - Contains no Active Ingredient

    ISSUE: FDA lab tests have confirmed that a counterfeit version of Roche’s Altuzan 400mg/16ml (bevacizumab),an injectable cancer medication, found in the U.S. contains no active ingredient. Even if the identified drugs were not counterfeit, Altuzan is not approved by FDA for use in the United States (it is an approved drug in Turkey).

     

    BACKGROUND: Medical practices obtained the counterfeit Altuzan and other unapproved products through foreign sources, in particular from Richards Pharma, also known as Richards Services, Warwick Healthcare Solutions, or Ban Dune Marketing Inc (BDMI).  Many, if not all, of the products sold and distributed through this distributor have not been approved by the FDA. Pictures of the counterfeit version of Altuzan are shown in the FDA statement. Packaging or vials found in the U.S. that claim to be Roche’s Altuzan with lot number B6021 should be considered counterfeit.

     

    RECOMMENDATION: Any medical practice that has obtained unapproved products, in particular from Richards Pharma, Richards Services, Warwick Healthcare Solutions, or Ban Dune Marketing Inc (BDMI), should stop using them and contact the FDA.  The products should be retained and securely stored until further notice by the FDA.

     

    FDA is asking the public to report suspect counterfeit products and other suspect products obtained from Richards Pharma, Richards Services, Warwick Healthcare Solutions, Ban Dune Marketing Inc (BDMI), or other sources:
    Call FDA’s Office of Criminal Investigations (OCI) at 800-551-3989, or  
    Visit OCI’s Web site (www.accessdata.fda.gov/scripts/email/oc/oci/contact.cfm), or
    Email - DrugSupplyChainIntegrity@fda.hhs.gov


    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

     

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

      

    [04/03/2012 - Drug Integrity and Supply Chain Security Statement - FDA]

    Latest Bevacizumab) clinical trials

    Bevacizumab) Reviews

    No reviews, be a first to report a side effect via side effect reporting form